The maraviroc expanded access program — safety and efficacy data from an open-label study-Reference-Cited by-同舟云学术

The maraviroc expanded access program — safety and efficacy data from an open-label study

Published:2015-01-23 Issue:1 Volume:16 Page:10-21
ISSN:1528-4336
Container-title:HIV Clinical Trials
language:en
Short-container-title:HIV Clinical Trials

Author:

Lazzarin Adriano,Reynes Jacques,Molina Jean-Michel,Valluri Srinivas,Mukwaya Geoffrey,Heera Jayvant,Craig Charles,van der Ryst Elna,Sierra-Madero Juan G.

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases

Link

http://www.tandfonline.com/doi/pdf/10.1179/1528433614Z.0000000002

Reference23 articles.

1. Selzentry [package insert]. Research Triangle Park, NC: ViiV Healthcare; 2014.

2. Celsentri [summary of product characteristics]. http://www.medicines.org.uk/emc/medicine/20386. Accessed May 19, 2014.

3. Maraviroc for Previously Treated Patients with R5 HIV-1 Infection

4. Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection

5. Two-Year Safety and Virologic Efficacy of Maraviroc in Treatment-Experienced Patients With CCR5-Tropic HIV-1 Infection: 96-Week Combined Analysis of MOTIVATE 1 and 2

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review on fluorinated nucleoside/non-nucleoside FDA-approved antiviral drugs;RSC Advances;2022

2. Maraviroc exposure is influenced by exogenous thyrotoxicosis;AIDS;2021-03-15

3. V3-Loop genotypes do not predict maraviroc susceptibility of CCR5-tropic virus or clinical response through week 48 in HIV-1–infected, treatment-experienced persons receiving optimized background regimens;Antiviral Chemistry and Chemotherapy;2021-01

4. Pyrogallol-Phloroglucinol-6,6-Bieckolon Attenuates Vascular Smooth Muscle Cell Proliferation and Phenotype Switching in Hyperlipidemia through Modulation of Chemokine Receptor 5;Marine Drugs;2020-07-27

5. Clinical use, efficacy, and durability of maraviroc for antiretroviral therapy in routine care: A European survey;PLOS ONE;2019-11-21